Outset Halts Tablo Sales for Home Use Pending FDA Review of New Features
As Outset has added features improving Tablo since the FDA first cleared it for use, it has now had to submit another 510(k) application to the FDA, thus limiting sales to acute facilities only.
Read the full article » | Posted 07-13-2022
Related Articles
- ISPD’s Spotlight Webinar Series 2026 Posted 03-12-2026
- Dr. Brigitte Schiller Shares Thoughts on Prescribing Nocturnal Home HD Posted 03-12-2026
- Dr. Chris Chan and Dr. Klement Yeung: Treat Home HD as an Established Modality Posted 03-12-2026
- How to Get Started: Your Path to Home Dialysis – New AKF Webinar Posted 03-12-2026

